Crossref
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Clinical Investigation · 2011
DOI: 10.4155/cli.10.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Investigation, 2011. Verfasst von Marta Letizia Hribal und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hribal, M. L., & Sesti, G. (2011). Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials. Clinical Investigation. https://doi.org/10.4155/cli.10.26
Vancouver
Hribal ML, Sesti G. Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials. Clinical Investigation. 2011. doi:10.4155/cli.10.26
BibTeX
@article{Hribal2011,
author = {Hribal, Marta Letizia and Sesti, Giorgio},
title = {Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials},
journal = {Clinical Investigation},
year = {2011},
doi = {10.4155/cli.10.26}
}
EUVIMED